Henry E. Schea
President chez Genopoietic SA
Postes actifs de Henry E. Schea
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Genopoietic SA
 Genopoietic SA BiotechnologyHealth Technology Part of AVAX Technologies, Inc., Genopoietic SA is a French company that researches and develops cell and gene therapy for cancer, autoimmune diseases, and orthopedics. The company is based in Paris, France. Genopoietic was acquired by AVAX Technologies, Inc. on August 24, 2000 for $198.62 million. | President | 21/10/2011 | - |
Historique de carrière de Henry E. Schea
Anciens postes connus de Henry E. Schea
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVAX TECHNOLOGIES, INC. | Conseiller Juridique Général | 04/01/2010 | 01/04/2016 |
Formation de Henry E. Schea
| University of Massachusetts | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| France | 2 |
Opérationnelle
| General Counsel | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AVAX TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genopoietic SA
Genopoietic SA BiotechnologyHealth Technology Part of AVAX Technologies, Inc., Genopoietic SA is a French company that researches and develops cell and gene therapy for cancer, autoimmune diseases, and orthopedics. The company is based in Paris, France. Genopoietic was acquired by AVAX Technologies, Inc. on August 24, 2000 for $198.62 million. | Health Technology |
- Bourse
- Insiders
- Henry E. Schea
- Expérience
